Ionis Pharmaceuticals, Inc. logo

Ionis Pharmaceuticals, Inc. (IONS)

Market Open
16 Oct, 03:15 PM
NASDAQ (NGS) NASDAQ (NGS)
$
43. 22
-0.9
-2.0399%
$
7.52B Market Cap
- P/E Ratio
- Div Yield
330,649 Volume
-3.43 Eps
$ 44.12
Previous Close
Add Transaction
Day Range
43.17 44.65
Year Range
42.08 86.74
Want to track IONS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ionis Pharmaceuticals, Inc. (IONS) Statistics

Valuation metrics

Market Cap 7.52B
Enterprise value 9.59B
Trailing P/E (ttm) -13.09
Forward P/E -121.81
PEG ratio 0.16
Price/Sales (ttm) 8.61
Price/Book (mrq) 17.03
Enterprise Value/Revenue 10.98
Enterprise Value/EBITDA -19.99

Overview

Shares outstanding 163.3M
Float 163.91M
Shares short 14.33M
% Held by insiders 0.01%
% Held by institutions 1.06%
Average volume (10 days) 4.86M
Average volume (90 days) 3.2M

Price summary

52-Week low 42.08
52-Week high 86.74
Beta 0.4
50-Day moving average 55.3
200-Day moving average 72.26

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.65%
Operating margin -0.68%

Operational effectiveness

Return on assets -0.19%
Return on equity -1.11%

Income Statement

Revenue (ttm) 943.71M
Revenue per share (ttm) 5.28
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 12.18M
EBITDA -369.24M
Net income to common (ttm) -381.39M
Diluted EPS (ttm) -3.41
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 2.68B
Total cash per share (mrq) 12.42
Total debt (mrq) 2.62B
Total Debt/Equity (mrq) 5.5
Current ratio (mrq) 7.88%
Book value per share (mrq) 2.65

Cash Flow

Cash flow statement -268.58M
Levered free cash flow (LFCF) -154.72M